PARADISE VALLEY HOSPITAL
1. Target Overview & Investment Thesis
PARADISE VALLEY HOSPITAL is a 230-bed suburban community hospital in SAN DIEGO, CA with $140.8M in net patient revenue and a -1.0% operating margin. The hospital serves a payer mix of 15.2% Medicare, 14.0% Medicaid, and 70.7% commercial.
Thesis: Undervalued. Our ML models identify $10.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.0% to 6.4% (+736bps).
| Net Revenue HCRIS | $140.8M |
| Current EBITDA COMPUTED | $-1.3M |
| Operating Margin COMPUTED | -1.0% |
| Occupancy HCRIS | 43.5% |
| Revenue / Bed COMPUTED | $612K |
| Net-to-Gross HCRIS | 36.4% |
| Distress Probability ML | 53.6% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -1.0% places it above the state median. Among 199 size-comparable peers (115-460 beds), the median margin is -4.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (115-460), prioritizing same-state peers. 199 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PARADISE VALLEY HOSPITAL (Target) | CA | 230 | $140.8M | -1.0% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
| LUCILE PACKARD CHILDRENS HOSPI | CA | 394 | $2.39B | -0.8% |
| UCI MEDICAL CENTER | CA | 397 | $1.90B | -2.5% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| RADY CHILDRENS HOSPITAL - SAN | CA | 401 | $1.82B | 14.8% |
| HARBOR-UCLA MEDICAL CENTER | CA | 369 | $1.54B | -6.4% |
| EL CAMINO HOSPITAL | CA | 388 | $1.34B | 11.7% |
| CHILDRENS HOSPITAL OF ORANGE C | CA | 334 | $1.31B | 0.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $90K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.3M |
| + RCM Uplift | +$10.4M |
| Pro Forma EBITDA | $9.0M |
| Current Margin | -1.0% |
| Pro Forma Margin | 6.4% |
| WC Released (1x) | $5.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-2.1M | $94.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-2.1M | $103.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.9M | $137.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.9M | $149.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-2.3M | $43.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-2.3M | $47.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 53.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 199 hospitals with 115-460 beds
- Same-state prioritization (n=200)
- Comp margins: P25=-16.7% / P50=-4.0% / P75=4.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.